AbbVie remains king in doctors' perception of immunology drugmakers, but J&J regains some ground
Just like last year, the Skyrizi and Rinvoq maker scored the highest by far in ZoomRx’s analysis of how healthcare providers view immunology drugmakers.
Just like last year, the Skyrizi and Rinvoq maker scored the highest by far in ZoomRx’s analysis of how healthcare providers view immunology drugmakers.
